FDA Inspection 1215040 - Bioreliance Corporation - August 04, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Bioreliance Corporation, with an inspection on August 4, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Bioreliance Corporation
Inspection Date: August 4, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 89149f6b-0201-4f3c-9500-60de669dfba4